Evidence map›Paper›PMID 21881515›Full record

ArticleEpidemiology (Cambridge, Mass.)2011

Hypertension and risk of renal cell carcinoma among white and black Americans.

Joanne S Colt, Kendra Schwartz, Barry I Graubard, Faith Davis, Julie Ruterbusch, Ralph DiGaetano, Mark Purdue, Nathaniel Rothman, Sholom Wacholder, Wong-Ho Chow

Open access · greenAbstract read
In one paragraph

Article in Epidemiology (Cambridge, Mass.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 8 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 8 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.International journal of environmental research and public health · 2018
    Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Impact of the COVID-19 pandemic on diagnosis of renal cell carcinoma and disease stage at presentation.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Joanne S ColtDivision of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7240, USA. coltj@mail.nih.gov
Kendra Schwartz
Barry I Graubard
Faith Davis
Julie Ruterbusch
Ralph DiGaetano
Mark Purdue
Nathaniel Rothman
Sholom Wacholder
Wong-Ho Chow
National Cancer Institute · USThe Barbara Ann Karmanos Cancer Institute · USChicago Department of Public Health · USDepartment of Health and Human Services · USNational Institutes of Health · USWestat (United States) · US

Funding

Cancer Risk in Human PopulationsZIACP010136 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI PURDUE, MARK · 2009 to 2025
$36.7M
CANCER RISK IN HUMAN POPULATIONSZ01CP010136 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SILVERMAN, DEBRA · 1997 to 2008
$5.1M
Therapeutic &Diagnostic Factors Related to Cancer RisKZ01CP010128 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI BRINTON, LOUISE · 1996 to 2008
$146k
Intramural NIH HHS Z01 CP010128Intramural NIH HHS Z01 CP010136NCI NIH HHS N02 CP011004NCI NIH HHS N02 CP011161NCI NIH HHS N02-CP-10128
6 · The paper itself

Abstract

backgroundRenal cell carcinoma and hypertension (a well-established renal cancer risk factor) are both more frequent among blacks than whites in the United States. The association between hypertension and renal cell carcinoma has not been examined in black Americans. We investigated the hypertension-renal cancer association by race, and we assessed the role of hypertension in the racial disparity of renal cancer incidence.

methodsParticipants were enrolled in a population-based case-control study in Detroit and Chicago during 2002-2007 (number of cases: 843 whites, 358 blacks; number of controls: 707 whites, 519 blacks). Participants reported their history of hypertension and antihypertensive drug use. We used unconditional logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for demographic characteristics, smoking, body mass index, and family history of cancer.

resultsHypertension doubled renal cancer risk (OR = 2.0 [CI = 1.7-2.5]) overall. For whites, the OR was 1.9 (CI = 1.5-2.4), whereas for blacks it was 2.8 (2.1-3.8) (P for interaction = 0.11). ORs increased with time after hypertension diagnosis (P for trend <0.001), reaching 4.1 (CI = 2.3-7.4) for blacks and 2.6 (CI = 1.7-4.1) for whites after 25 years. ORs for poorly controlled hypertension were 4.5 (CI = 2.3-8.8) for blacks and 2.1 (CI = 1.2-3.8) for whites. If these estimates correctly represent causal effects and if, hypothetically, hypertension could be prevented entirely among persons aged 50-79 years, the black/white disparity in renal cancer could be reversed among women and reduced by two-thirds among men.

conclusionsHypertension is a risk factor for renal cancer among both blacks and whites, and might explain a substantial portion of the racial disparity in renal cancer incidence. Preventing and controlling hypertension might reduce renal cancer incidence, adding to the known benefits of blood pressure control for heart disease and stroke reduction, particularly among blacks.

Indexed as

AdultAgedAge FactorsAntihypertensive AgentsBlack or African AmericanBlack PeopleCarcinoma, Renal CellCase-Control StudiesConfidence IntervalsFemaleHealth Status DisparitiesHumansHypertensionIncidenceKidney NeoplasmsLogistic ModelsAntihypertensive Agents

Identifiers

PMID21881515
PMCPMC3188386
OpenAlexW1970348172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.